LTRN Covered Call Strategy

LTRN (Lantern Pharma Inc.), in the Healthcare sector, (Biotechnology industry), listed on NASDAQ.

Lantern Pharma Inc. is a clinical-stage biotechnology firm dedicated to revolutionizing drug development through the strategic application of artificial intelligence, machine learning, and comprehensive genomic data analysis. Their primary drug candidate, LP-100, is currently undergoing Phase II clinical trials, targeting metastatic, castration-resistant prostate cancer. The company is also advancing LP-300 as a potential combination therapy for non-small cell lung cancer adenocarcinoma, specifically in individuals who are non-smokers or have never smoked. Furthermore, their preclinical pipeline includes LP-184, an alkylating agent engineered to inflict DNA damage upon cancer cells that either overexpress specific biomarkers or exhibit mutations within their DNA repair pathways. Beyond these, Lantern Pharma maintains an antibody-drug conjugate (ADC) program for diverse cancer treatments. Central to their operations is the RADR artificial intelligence platform, which synergizes molecular data through advanced big data analytics and machine learning capabilities.

LTRN (Lantern Pharma Inc.) trades in the Healthcare sector, specifically Biotechnology, with a market capitalization of approximately $33.8M, a beta of 2.34 versus the broader market, a 52-week range of 1.11-4.75, average daily share volume of 215K, a public-listing history dating back to 2020, approximately 16 full-time employees. These structural characteristics shape how LTRN stock options price implied volatility around earnings windows, capital events, and macro-driven sector rotations.

A beta of 2.34 indicates LTRN has historically moved more than the broader market, amplifying both the directional payoff and the realized volatility relative to an index-equivalent position.

What is a covered call on LTRN?

A covered call pairs long stock with a short out-of-the-money call, collecting premium and capping upside above the short strike in exchange for income.

LTRN snapshot

As of August 14, 2026, spot at $2.68, ATM IV 188.30%, IV rank 38.62%, expected move 53.98%. The covered call on LTRN below is built from the end-of-day chain, with strikes snapped to listed contracts and premiums pulled from the bid/ask midpoint at a 35-day expiry.

Why this covered call structure on LTRN specifically: LTRN IV at 188.30% is mid-range versus its 1-year history, so the credit collected on a LTRN covered call sits in line with its long-run distribution, with a market-implied 1-standard-deviation move of approximately 53.98% (roughly $1.45 on the underlying). The 35-day window matched to the front-month expiry keeps theta exposure bounded while still capturing the post-snapshot move; longer-dated LTRN expiries trade a higher absolute premium for lower per-day decay. Position sizing on LTRN should anchor to the underlying notional of $2.68 per share and to the trader's directional view on LTRN stock.

LTRN covered call setup

The LTRN covered call below is built from the end-of-day chain, with each option leg priced at the bid/ask midpoint of its listed strike. With LTRN at $2.68 on that close, the first option leg uses a $2.81 strike; additional legs (when the strategy has them) anchor to spot-relative offsets. Premiums come from the bid/ask midpoint on the listed LTRN chain at a 35-day expiry; the cross-strike IV skew is reflected directly in the per-leg values rather than approximated. Quantity sizing assumes one contract per option leg (or 100 LTRN shares for the stock leg in covered calls and collars).

ActionTypeStrike / BasisPremium (est)
Buy 100 sharesStock$2.68long
Sell 1Call$2.81N/A

LTRN covered call risk and reward

Net Premium / Debit
N/A
Max Profit (per contract)
Unbounded
Max Loss (per contract)
Unbounded
Breakeven(s)
None on modeled curve
Risk / Reward Ratio
N/A

Max profit equals short-strike minus cost basis plus premium times 100; max loss is cost basis minus premium (at zero). Breakeven is cost basis minus premium.

LTRN covered call payoff curve

Modeled P&L at expiration across a range of underlying prices for the covered call on LTRN. Each row is one sampled price point from the computed payoff curve; the full curve uses 200 price points internally before being summarized into 10 rows here.

When traders use covered call on LTRN

Covered calls on LTRN are an income strategy run on existing LTRN stock positions; traders typically sell calls at 25-35 delta with 30-45 days to expiration to balance premium against upside cap.

LTRN thesis for this covered call

The market-implied 1-standard-deviation range for LTRN extends from approximately $1.23 on the downside to $4.13 on the upside. A LTRN covered call collects premium on an existing long LTRN position, trading off upside above the short call strike for immediate income; the short strike selection should reflect the trader's view on whether LTRN will breach that level within the expiration window. Current LTRN IV rank near 38.62% is mid-range against its 1-year distribution, so the IV signal is neutral; the covered call thesis on LTRN should anchor more to the directional view and the expected-move geometry. As a Healthcare name, LTRN options can move on sector-level news flow (peer earnings, regulatory updates, industry-specific macro data) in addition to LTRN-specific events.

LTRN covered call positions are structurally neutral to slightly bullish; the modeled P&L assumes European-style exercise at expiration and ignores early assignment, transaction costs, dividends paid before expiry on the stock leg (when present), and the bid-ask spread on the listed chain. LTRN positions also carry Healthcare sector concentration risk; news flow inside the sector (peer earnings, regulatory shifts, supply-chain headlines) can move LTRN alongside the broader basket even when LTRN-specific fundamentals are unchanged. Short-premium structures like a covered call on LTRN carry tail risk when realized volatility exceeds the implied move; review historical LTRN earnings reactions and macro stress periods before sizing. Always rebuild the position from current LTRN chain quotes before placing a trade.

Frequently asked questions

What is a covered call on LTRN?
A covered call on LTRN is the covered call strategy applied to LTRN (stock). The strategy is structurally neutral to slightly bullish: A covered call pairs long stock with a short out-of-the-money call, collecting premium and capping upside above the short strike in exchange for income. With LTRN stock at $2.68 on the most recent close, the strikes shown on this page are snapped to the nearest listed LTRN chain strike and the premiums come straight from that session's bid/ask midpoint.
How are LTRN covered call max profit and max loss calculated?
Max profit equals short-strike minus cost basis plus premium times 100; max loss is cost basis minus premium (at zero). Breakeven is cost basis minus premium. For the LTRN covered call priced from the end-of-day chain at a 30-day expiry (ATM IV 188.30%), the computed maximum profit is unbounded per contract and the computed maximum loss is unbounded per contract. Live intraday quotes will differ as the chain moves through the trading session.
What is the breakeven for a LTRN covered call?
The breakeven for the LTRN covered call priced on this page is no defined breakeven on the modeled curve at expiration, derived from the end-of-day chain's premiums. Breakeven is the underlying price at which the strategy's P&L crosses zero ignoring transaction costs and assignment risk. The LTRN market-implied 1-standard-deviation expected move in the same options snapshot is approximately 53.98%; if the move sits well outside the breakeven distance, the structure's risk-reward becomes correspondingly tighter.
When should you consider a covered call on LTRN?
Covered calls on LTRN are an income strategy run on existing LTRN stock positions; traders typically sell calls at 25-35 delta with 30-45 days to expiration to balance premium against upside cap.
How does current LTRN implied volatility affect this covered call?
LTRN ATM IV is at 188.30% with IV rank near 38.62%, which is mid-range against its 1-year history. Strategy selection depends more on directional thesis and expected move than on a strong IV signal.

Related LTRN analysis